To hear about similar clinical trials, please enter your email below
Trial Title:
Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients
NCT ID:
NCT05899543
Condition:
Chronic Lymphocytic Leukemia
Conditions: Official terms:
Leukemia
Leukemia, Lymphoid
Leukemia, Lymphocytic, Chronic, B-Cell
Conditions: Keywords:
Chronic Lymphocytic Leukemia
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
This research study aims to address the limited understanding of the challenges faced by
specific demographic groups of chronic lymphocytic leukemia patients in their
participation in clinical trials.
This trial will scrutinize the experiences of patients diagnosed with chronic lymphocytic
leukemia as they take part in a separate medical intervention clinical trial. The focus
will be on tracking the rates of completion and withdrawal among these individuals.
It will also try to analyze data from the perspective of different demographic groups to
check for recurring trends which might yield insights for the sake of future chronic
lymphocytic leukemia patients.
Criteria for eligibility:
Study pop:
Chronic lymphocytic leukemia patients who are actively participating in a clinical study,
but have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patient has been diagnosed with chronic lymphocytic leukemia
- Patient is a minimum of 18 years or older
- Able to comprehend the investigational nature of the protocol and provide informed
consent
Exclusion Criteria:
- Pregnant or lactating women
- Patients who are currently receiving any other investigational drug
- Any mental or medical condition that prevents the patient from giving informed
consent or participating in the trial
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Start date:
July 2024
Completion date:
July 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05899543
